BRNS
Barinthus Biotherapeutics plc Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website barinthusbio.com
- Employees(FY) 107
- ISIN US91864C1071
Performance
+13.94%
1W
+24.06%
1M
-7.5%
3M
-15.91%
6M
-69.92%
YTD
-68.47%
1Y
Profile
Barinthus Biotherapeutics plc, a clinical-stage biopharmaceutical company, engages in developing novel T cell immunotherapeutics to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. It is advancing a pipeline of product candidates across a range of therapeutic areas, including VTP-300, an immunotherapeutic candidate designed as a potential component of a functional cure for chronic HBV infection; VTP-200, a non-surgical product candidate for persistent high-risk human papillomavirus (HPV); VTP-1000, an autoimmune candidate designed to utilize the SNAP-TI platform to treat patients with celiac disease; VTP-850, a second-generation immunotherapeutic candidate designed to treat recurrent prostate cancer; and VTP-1100, a preclinical cancer candidate designed to utilize the SNAP-CI platform to treat patients with HPV-related cancer. The company was formerly known as Vaccitech plc and changed its name to Barinthus Biotherapeutics plc in November 2023. Barinthus Biotherapeutics plc was founded in 2016 and is headquartered in Harwell, the United Kingdom.
Technical Analysis of BRNS 2024-12-24
Technical Scores and Rating
Moving Average Score
Oscillator Score
Technical Rating
Recent News & Updates
- 2024-11-25 03:01
- 2024-11-14 22:02
- 2024-11-14 22:01
- 2024-11-05 19:00
- 2024-10-30 20:00
- 2024-09-30 20:00
- 2024-09-23 20:00
- 2024-08-07 20:00
- 2024-07-31 20:00
- 2024-06-12 04:01
- 2024-06-05 23:15
- 2024-05-21 20:00
- 2024-05-13 01:53
- 2024-05-12 20:00
- 2024-04-30 19:00
- 2024-04-18 04:10
- 2024-03-20 01:52
- 2024-03-19 20:15
- 2024-01-05 03:01
- 2023-12-20 18:31
- 2023-11-09 03:24
- 2023-11-09 03:01
- 2023-11-09 03:01
- 2023-11-05 20:05
- 2023-10-03 18:23
- 2023-09-12 20:00
- 2023-08-09 20:00
- 2023-08-08 19:37
- 2023-07-19 08:34
- 2023-06-28 19:11
Page 1 of 4
previousnext
Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.